In response to the growing number of HIV infected adolescents and young adults in this country and abroad, the Adolescent Trials Network (ATN) will continue to create opportunities to conduct an array of studies to better understand this infection. The ATN will specifically seek to better understand how infection with this virus can be prevented, how infection is initiated, how the infection evolves in those infected, how progression of illness can be slowed, and how seriously ill persons can be successfully treated. Efforts to prevent infection will be carried out through the community-based Connect to Protect (C2P) project and will focus on continued efforts to develop the primary prevention infrastructure necessary for vaccine research, microbicide research, pre-exposure prophylaxis (PrEP), and theoretically based behavioral interventions to reduce risk behaviors. Secondary prevention will focus on preserving the health of HIV infected youth. Crucial to these efforts will be studies that will identify infected youth early and successfully link them to care. Similarly important will be studies of the pharmacogenomics of antiretroviral agents by themselves and in combination with other drugs and studies aimed at increasing adherence, promoting positive behaviors, and limiting risks in all infected adolescents. Tertiary prevention efforts will focus on the development of therapeutic options for adolescents further along in their disease process, as well as to identifying psychological and ancillary services that might help improve health. The ATN will similarly promote studies that look at the life-decision making process, coping mechanisms to deal with life-threatening illness, and end-of-life planning.
This study seeks to find ways to understand, prevent, and treat HIV infection in adolescents and young adults. It will study how communities can make changes to prevent the infection as well as studying how individuals infected with the virus can be kept healthy. Finally, it will try to find ways to restore the health of youth who have become very ill as a result of this infection.
|Harper, Gary W; Tyler, April Timmons; Bruce, Douglas et al. (2016) Drugs, Sex, and Condoms: Identification and Interpretation of Race-Specific Cultural Messages Influencing Black Gay and Bisexual Young Men Living with HIV. Am J Community Psychol 58:463-476|
|Harper, Gary W; Bruce, Douglas; Hosek, Sybil G et al. (2014) Resilience processes demonstrated by young gay and bisexual men living with HIV: implications for intervention. AIDS Patient Care STDS 28:666-76|
|Harper, Gary W; Fernandez, Isabel M; Bruce, Douglas et al. (2013) The role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with HIV. AIDS Behav 17:213-23|
|Lin, Alison J; Dudek, Julia C; Francisco, Vincent T et al. (2012) Challenges and approaches to mobilizing communities for HIV prevention among young men who have sex with men of color. J Prev Interv Community 40:149-64|
|Reed, Sarah J; Miller, Robin Lin; Francisco, Vincent T et al. (2012) Programmatic capacity and HIV structural change interventions: influences on coalitions' success and efficiency in accomplishing intermediate outcomes. J Prev Interv Community 40:118-30|
|Doll, Mimi; Harper, Gary W; Robles-Schrader, Grisel M et al. (2012) Perspectives of community partners and researchers about factors impacting coalition functioning over time. J Prev Interv Community 40:87-102|
|Willard, Nancy; Chutuape, Kate; Stines, Stephanie et al. (2012) Bridging the gap between individual-level risk for HIV and structural determinants: using root cause analysis in strategic planning. J Prev Interv Community 40:103-17|
|Robles-Schrader, Grisel M; Harper, Gary W; Purnell, Marjorie et al. (2012) Differential challenges in coalition building among HIV prevention coalitions targeting specific youth populations. J Prev Interv Community 40:131-48|
|Barnes, William; D'Angelo, Lawrence; Yamazaki, Michiyo et al. (2010) Identification of HIV-infected 12- to 24-year-old men and women in 15 US cities through venue-based testing. Arch Pediatr Adolesc Med 164:273-6|